Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel

Yair Goldberg, Micha Mandel, Yonatan Woodbridge, Ronen Fluss, Ilya Novikov, Rami Yaari, Arnona Ziv, Laurence Freedman, Amit Huppert
doi: https://doi.org/10.1101/2021.04.20.21255670

Article usage

Article usage: April 2021 to November 2024

AbstractFullPdf
Apr 2021128452255816
May 20212179292833496
Jun 2021138116157033
Jul 20211807918339830
Aug 202130216313426434
Sep 20211333213605084
Oct 2021117396917616
Nov 202166614342810
Dec 202146673392809
Jan 202240032751886
Feb 202232423242023
Mar 20221862162910
Apr 20221386149770
May 2022975118469
Jun 202286145612
Jul 202281653570
Aug 202276638591
Sep 202275424477
Oct 202274937337
Nov 202255848336
Dec 202249618157
Jan 202353119186
Feb 202349526101
Mar 202351017108
Apr 202340623108
May 202338614123
Jun 20233241791
Jul 2023351688
Aug 202347426100
Sep 202339620105
Oct 202338211107
Nov 202328630227
Dec 202321322131
Jan 202429216155
Feb 20243178160
Mar 202435512176
Apr 202438194318
May 20243561670
Jun 20243951797
Jul 2024311891
Aug 20243331680
Sep 20242591594
Oct 20242571381
Nov 20241981069
Back to top
Posted April 24, 2021.
Download PDF
Data/Code
Email
Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel
Yair Goldberg, Micha Mandel, Yonatan Woodbridge, Ronen Fluss, Ilya Novikov, Rami Yaari, Arnona Ziv, Laurence Freedman, Amit Huppert
medRxiv 2021.04.20.21255670; doi: https://doi.org/10.1101/2021.04.20.21255670
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area